Pharmaceuticals
Sun Pharma gets US nod for generic leukemia drug
05 Dec 2015
Turing Pharma halves Daraprim price hike from 5,000% to 2,500%
27 Nov 2015
The small biotech company is now cutting what it charged hospitals, by up to 50 per cent for Daraprim, its parasitic infection drug
FDA threatens Dr Reddy’s with US import ban
26 Nov 2015
Turing does volte face on cutting price of drug Daraprim
26 Nov 2015
After virtually promising to cut the price of Daraprim - which it hiked by 50 times after acquiring it in August - New York based start-up Turing Pharmaceuticals now says it will take other measures to make the drug affordable
Shire preparing to mount new bid for Baxalta
25 Nov 2015
British drugmaker Shire Plc is preparing to table a new takeover offer for Baxalta, almost four months after the US biotech firm rejected its unsolicited $30-billion bid
US politicians unite to flay Pfizer-Allergan deal
24 Nov 2015
Democratic presidential front-runner Hillary Clinton said the deal would “leave US taxpayers holding the bag”, while her Republican rival Donald Trump called it “disgusting”
Pfizer to take over Allergan in historic $150-bn deal
23 Nov 2015
The deal, the largest ever in the healthcare sector, will make Pfizer the world’s biggest drug maker, but the tax-cutting ‘inversion’ move is sure to draw political ire
Scientists in China find gene that could breach last-resort antibiotics
21 Nov 2015
Polymyxins are considered the last line of defence when other antibiotics prove ineffective
NIH announces end to support for invasive research on chimpanzees
21 Nov 2015
In 2013, the US Fish and Wildlife Service gave research chimps endangered-species protection, barring scientists from conducting stressful or invasive research on them, unless the work benefited chimps in the wild
Pfizer said to be in $150-bn merger talks with Allergan
19 Nov 2015
Merger talks are being held between US pharmaceutical giant Pfizer and Irish drug maker Allergan Plc, to create a global pharmaceutical behemoth worth over $300 billion
Cabinet nod for National Animal Resource Facility for Bio-medical Research at Genome Valley, Hyderabad
18 Nov 2015
Gilead wins US FDA nod for TAF-based HIV drug
10 Nov 2015
Sanofi mulls selling animal health unit and European generics business worth over $13 bn
07 Nov 2015
AstraZeneca to buy ZS Pharma for $2.7 bn
06 Nov 2015
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
